X ET 59783#SR-12411 White 1 WILFLEX OASIS HYDROPHIL 11835PFW EPIC QUICK WHITE

WHITE UV TRITAN ITW WHITE ZYLAR XES133147A WILFLEX OASIS HYDRATE HO WHT

19000WOBB WILFLEX OASIS BLEED BLOCKER BK GEON C80B0 WHITE 1225 GEON C8000 WHITE

Homepage // News Center // New ColorMatrix™ Optica™ Toners from Avient Correct Color, Enhance Performance in rPET The solution also incorporates the added benefits of ColorMatrix™ SmartHeat™ RHC technology for improved processing performance. Examples include: •    Barrier technologies that preserve the shelf-life and quality of food, beverages, medicine and other perishable goods through high-performance materials that require less plastic •    Light-weighting solutions that replace heavier traditional materials like metal, glass and wood, which can improve fuel efficiency in all modes of transportation •    Breakthrough technologies that minimize wastewater and improve the recyclability of materials and packaging across a spectrum of end uses

Senior management uses pre-special gross margin, adjusted operating income, adjusted EPS and working capital to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and that current levels may serve as a base for future performance. Platform operating income mix percentage 2005Y 2008Y 2011Y Global Specialty Engineered Materials $ 0.4 $ 17.6 $ 45.9 Global Color, Additives and Inks 4.3 28.1 43.4 Specialty Platform $ 4.7 $ 45.7 $ 89.3 Performance Products and Solutions 75.7 31.3 62.4 Distribution 19.5 28.1 56.0 SunBelt Joint Venture 91.9 28.6 5.0 Corporate (51.5) (425.1) 20.3 Operating income (loss) GAAP $ 140.3 $ (291.4) $ 233.0 Less: Corporate operating expense (income) 51.5 425.1 (20.3) Operating income excluding Corporate $ 191.8 $ 133.7 $ 212.7 Specialty platform operating mix percentage 2% 34% 42% Pro forma platform operating income mix percentage 2007 Pro forma 2011Y Specialty Platform $ 30.6 $ 89.3 Pro forma ColorMatrix - 27.7 Specialty Platform pro forma ColorMatrix $ 30.6 $ 117.0 Performance Products and Solutions 65.8 62.4 Distribution 22.1 56.0 SunBelt Joint Venture 34.8 5.0 Corporate (73.3) 20.3 Operating income pro forma ColorMatrix $ 80.0 $ 260.7 Less: Corporate and SunBelt operating income 73.3 (25.3) Operating income excluding Corporate operating income $ 153.3 $ 235.4 Specialty platform operating mix percentage 20% 50% Adjusted EPS 2006Y 2007Y 2008Y 2009Y 2010Y 2011Y Net Income $ 130.9 $ 40.9 $ (417.0) $ 106.7 $ 162.6 $ 172.6 SunBelt and OxyVinyls equity earnings, after tax (68.5) (26.1) (20.8) (19.0) (14.7) (3.7) Special items, after tax (21.2) 41.4 310.0 (31.0) 15.8 (30.5) Tax adjustments (30.0) (30.7) 147.2 (44.9) (88.3) (42.3) Adjusted net income $ 11.2 $ 25.5 $ 19.4 $ 11.8 $ 75.4 $ 96.1 Diluted shares 92.8 93.1 92.7 93.4 96.0 94.3 Adjusted EPS $ 0.12 $ 0.27 $ 0.21 $ 0.13 $ 0.79 $ 1.02 Adjusted EPS Q1 2011 Q1 2012 Net Income $ 110.2 $ 20.2 SunBelt equity earnings, after tax (3.7) - Special items, after tax (79.8) 6.1 Tax adjustments (1.5) 0.1 Adjusted net income $ 25.2 $ 26.4 Diluted shares 96.4 90.7 Adjusted EPS $ 0.26 $ 0.29 Platform sales and operating income (OI) 2005 2006 2007 2008 2009 2010 2011 Global Specialty Engineered Materials Sales $ 282.5 $ 345.3 $ 384.4 $ 514.0 $ 402.9 $ 517.4 $ 575.1 Global Color, Additives and Inks Sales 503.7 531.8 560.5 554.3 459.8 527.4 544.6 Specialty Platform Sales $ 786.2 $ 877.1 $ 944.9 $ 1,068.3 $ 862.7 $ 1,044.8 $ 1,119.7 Performance Products and Solutions Sales 1,136.3 1,166.2 1,086.8 1,001.4 667.7 776.3 865.4 PolyOne Distribution Sales 679.2 732.8 744.3 796.7 625.1 911.9 996.5 Corporate and Eliminations (151.1) (153.7) (133.3) (127.7) (94.8) (111.1) (118.1) Total Sales $ 2,450.6 $ 2,622.4 $ 2,642.7 $ 2,738.7 $ 2,060.7 $ 2,621.9 $ 2,863.5 Pro forma ColorMatrix Sales 196.0 Total sales pro forma ColorMatrix $ 3,059.5 Global Specialty Engineered Materials OI $ 0.4 $ 3.9 $ 4.9 $ 17.6 $ 20.6 $ 49.7 $ 45.9 Global Color, Additives and Inks OI 4.3 8.9 25.7 28.1 25.2 37.7 43.4 Specialty Platform OI $ 4.7 $ 12.8 $ 30.6 $ 45.7 $ 45.8 $ 87.4 $ 89.3 Performance Products and Solutions OI 75.7 64.2 65.8 31.3 33.1 54.0 62.4 PolyOne Distribution OI 19.5 19.2 22.1 28.1 24.8 42.0 56.0 Sunbelt Joint Venture OI 91.9 102.9 34.8 28.6 25.5 18.9 5.0 Corporate and eliminations (21.8) (4.6) (25.5) (28.9) (40.8) (32.5) (26.4) Special items (29.7) 39.1 (47.8) (396.2) 48.7 4.8 46.7 Operating income (loss) GAAP $ 140.3 $ 233.6 $ 80.0 $ (291.4) $ 137.1 $ 174.6 $ 233.0 Sunbelt equity income (72.5) (107.0) (40.8) (32.5) (29.7) (23.1) (5.7) Special items 29.7 (39.1) 47.8 396.2 (48.7) (4.8) (46.7) Operating income adjusted $ 97.5 $ 87.5 $ 87.0 $ 72.3 $ 58.7 $ 146.7 $ 180.6 Operating income pro forma ColorMatrix 27.7 Operating income adjusted pro forma ColorMatrix $ 208.3 Global Specialty Engineered Materials - OI as a percentage of sales 0.1% 1.1% 1.3% 3.4% 5.1% 9.6% 8.0% Global Color, Additives and Inks - OI as a percentage of sales 0.9% 1.7% 4.6% 5.1% 5.5% 7.1% 8.0% Specialty platform OI as a percentage of sales 0.6% 1.5% 3.2% 4.3% 5.3% 8.4% 8.0% Specialty platform OI as a percentage of sales - pro forma ColorMatrix 8.9% Global Color, Additives and Inks OI as a percentage of sales – pro forma ColorMatrix 9.6% PP&S operating OI as a percentage of sales 6.7% 5.5% 6.1% 3.1% 5.0% 7.0% 7.2% Distribution OI as a percentage of sales 2.9% 2.6% 3.0% 3.5% 4.0% 4.6% 5.6% PolyOne OI adjusted, as a percentage of sales 4.0% 3.3% 3.3% 2.6% 2.8% 5.6% 6.3% PolyOne OI adjusted, pro forma for ColorMatrix, as a percent of sales 6.8% Operating income (OI) Q1 2011 Q1 2012 Global Specialty Engineered Materials OI $ 14.0 $ 11.8 Global Color, Additives and Inks OI 11.2 17.3 Specialty Platform OI $ 25.2 $ 29.1 Performance Products and Solutions OI 14.3 17.8 PolyOne Distribution OI 14.7 16.7 Corporate and eliminations (1.6) (10.2) Special items 127.2 (8.5) Operating income (loss) GAAP $ 179.8 $ 44.9 Research and Development (R&D) – Pro forma ColorMatrix 2011 PolyOne R&D $ 36.9 ColorMatrix R&D 3.6 Pro forma R&D $ 40.5 Gross Margin as a percentage of Sales 2006 2011 2011 Pro forma ColorMatrix Specialty platform sales $ 877.1 $ 1,119.7 $ 1,315.7 Specialty platform gross margin 125.2 263.4 345.9 Specialty platform gross margin percentage 14.3 % 23.5 % 26.3 % Average Debt Q4 2010 Q1 2011 Q2 2011 Q3 2011 Q4 2011 Average PolyOne Debt $ 452.9 $ 432.9 $ 432.9 $ 432.9 $ 707.0 n/a Pro forma ColorMatrix 274.1 274.1 274.1 274.1 - n/a Total Debt $ 727.0 $ 707.0 $ 707.0 $ 707.0 $ 707.0 $ 711.0 Average Equity Q4 2010 Q1 2011 Q2 2011 Q3 2011 Q4 2011 Average PolyOne $ 516.0 $ 615.2 $ 629.6 $ 608.5 $ 588.3 $ 591.5

Formulations for material performance over 300°F (150°C). Transcend™ Precolored Gray and White PSU achieved accurate color match to non-polysulfone (PSU) components Colorant Chromatics™ Precolored Gray and Precolored White PSU able to withstand steam sterilization in an autoclave

MEVOPUR COLORANTS • Standard colors in PP and PE to shorten time-to-market • Custom colors matched to Pantone, RAL or other color reference • White colorants for pharmaceutical packaging for LDPE, HDPE and PP with opacity to reach USP chapter MEVOPUR FUNCTIONAL ADDITIVES • Antistatic formulation with good flow/impact for injection molding • Amide- and amine-free antistatic for film in contact with API (Active Pharmaceutical Ingredients) • UV blocking for transparent PP and PE packaging to meet USP chapter • Non-migrating friction reduction/processing aid for PE and PP • Laser marking/welding additive for fast, reliable marking/assembly • MVTR (Moisture Vapor Transmission Rate) reduction for HDPE to improve shelf-life • Thermal protection of the polymer during processing • Gamma/e-beam sterilization protection for PP (up to 50kGy) with color compensation for reduced yellowing REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU* APPLICATION BULLETIN * FDA/EU compliance information available upon request Bormed™ is a registered trademark of Borealis Healthcare use limitations apply—see below. Some of the information arises from laboratory work with small-scale equipment which may not provide a reliable indication of performance or properties obtained or obtainable on larger-scale equipment. You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.

Some of the information arises from laboratory work with small-scale equipment which may not provide a reliable indication of performance or properties obtained or obtainable on larger-scale equipment. You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product. COLOR RAL REFERENCE COLOR RAL REFERENCE 1015 Brown/12 6026 Green/14 1034 Yellow/14 6032 Green/20 1018 Yellow/19 7004 Grey/21 1003 Yellow/20 8025 Brown/14 3020 Red/15 9022 Pearl Grey/1 5005 Blue/35 9010 White/5 5000 Blue/36

Download this free study to determine if PK can address POM’s toxicity and sustainability issues without sacrificing performance. Evaluating the Performance of PKE for POM Replacement Download White Paper

Forward‐looking statements give current expectations or forecasts of future events and are not guarantees of future performance.    • PolyOne’s chief operating decision makers use these financial measures to  monitor and evaluate the ongoing performance of the Company and each  business segment and to allocate resources.  Senior management uses adjusted operating income, adjusted EPS, and working capital to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and that current levels may serve as a base for future performance.